Pamela A. Chambers

414 total citations
16 papers, 336 citations indexed

About

Pamela A. Chambers is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Pamela A. Chambers has authored 16 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Organic Chemistry, 4 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in Pamela A. Chambers's work include Synthesis and biological activity (2 papers), Attention Deficit Hyperactivity Disorder (2 papers) and Enzyme Catalysis and Immobilization (2 papers). Pamela A. Chambers is often cited by papers focused on Synthesis and biological activity (2 papers), Attention Deficit Hyperactivity Disorder (2 papers) and Enzyme Catalysis and Immobilization (2 papers). Pamela A. Chambers collaborates with scholars based in United States and United Kingdom. Pamela A. Chambers's co-authors include R. A. DAINES, Lawrence I. Kruse, Walter E. DeWolf, Paula J. Goodhart, Francis R. Pfeiffer, Alex K. Konstantinidis, Daniel R. Gentry, Sanjay S. Khandekar, Carol Silverman and Hong Xiang and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

Pamela A. Chambers

16 papers receiving 312 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pamela A. Chambers United States 10 149 113 80 46 36 16 336
Lain‐Yen Hu United States 12 242 1.6× 145 1.3× 116 1.4× 38 0.8× 63 1.8× 22 463
John M. Wetzel United States 14 192 1.3× 230 2.0× 86 1.1× 40 0.9× 21 0.6× 21 564
Michael Arnold Germany 11 111 0.7× 129 1.1× 30 0.4× 43 0.9× 21 0.6× 22 344
Hiroshi Ohtaka United States 13 170 1.1× 207 1.8× 80 1.0× 52 1.1× 22 0.6× 33 406
Vittorio Vecchietti Italy 11 312 2.1× 173 1.5× 215 2.7× 32 0.7× 37 1.0× 26 503
R. Gnana Ravi United States 9 209 1.4× 143 1.3× 40 0.5× 16 0.3× 25 0.7× 16 430
Jayana P. Lineswala United States 5 118 0.8× 123 1.1× 71 0.9× 28 0.6× 100 2.8× 6 316
Kethireddy V.V. Ananthalakshmi Kuwait 13 147 1.0× 183 1.6× 122 1.5× 25 0.5× 56 1.6× 21 463
Pascal Rigollier Switzerland 11 269 1.8× 158 1.4× 179 2.2× 37 0.8× 27 0.8× 15 515
Meena Patel United States 10 130 0.9× 158 1.4× 93 1.2× 95 2.1× 19 0.5× 15 412

Countries citing papers authored by Pamela A. Chambers

Since Specialization
Citations

This map shows the geographic impact of Pamela A. Chambers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamela A. Chambers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamela A. Chambers more than expected).

Fields of papers citing papers by Pamela A. Chambers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pamela A. Chambers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamela A. Chambers. The network helps show where Pamela A. Chambers may publish in the future.

Co-authorship network of co-authors of Pamela A. Chambers

This figure shows the co-authorship network connecting the top 25 collaborators of Pamela A. Chambers. A scholar is included among the top collaborators of Pamela A. Chambers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pamela A. Chambers. Pamela A. Chambers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Khandekar, Sanjay S., Daniel R. Gentry, Glenn S. Van Aller, et al.. (2001). Identification, Substrate Specificity, and Inhibition of theStreptococcus pneumoniae β-Ketoacyl-Acyl Carrier Protein Synthase III (FabH). Journal of Biological Chemistry. 276(32). 30024–30030. 85 indexed citations
2.
Aiyar, Nambi, R. A. DAINES, Jyoti Disa, et al.. (2001). Pharmacology of SB-273779, a Nonpeptide Calcitonin Gene-Related Peptide 1 Receptor Antagonist. Journal of Pharmacology and Experimental Therapeutics. 296(3). 768–775. 44 indexed citations
3.
Sarau, Henry M., James J. Foley, Dulcie B. Schmidt, et al.. (1999). In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4receptor antagonist with anti-inflammatory activity. Prostaglandins Leukotrienes and Essential Fatty Acids. 61(1). 55–64. 6 indexed citations
4.
DAINES, R. A., Pamela A. Chambers, James J. Foley, et al.. (1996). (E)-3-[6-[[(2,6-Dichlorophenyl)thio]methyl]-3-(2-phenylethoxy)-2-pyridinyl]-2- propenoic Acid:  A High-Affinity Leukotriene B4 Receptor Antagonist with Oral Antiinflammatory Activity. Journal of Medicinal Chemistry. 39(19). 3837–3841. 13 indexed citations
5.
Pendrak, Israil & Pamela A. Chambers. (1995). Improved Synthesis of RG-14893, a High-Affinity Leukotriene B4 Receptor Antagonist, via a Photochemical Wolff Rearrangement. The Journal of Organic Chemistry. 60(10). 3249–3251. 9 indexed citations
6.
DAINES, R. A., Pamela A. Chambers, Drake S. Eggleston, et al.. (1994). (E)-3-[[[[6-(2-Carboxyethenyl)-5-[[8-(4-methoxyphenyl)octyl]oxy]-2-pyridinyl]methyl]thio]methyl]benzoic Acid and Related Compounds: High Affinity Leukotriene B4 Receptor Antagonists. Journal of Medicinal Chemistry. 37(20). 3327–3336. 13 indexed citations
7.
DAINES, R. A., Pamela A. Chambers, Israil Pendrak, et al.. (1993). Trisubstituted pyridine leukotriene B4 receptor antagonists: synthesis and structure-activity relationships. Journal of Medicinal Chemistry. 36(22). 3321–3332. 10 indexed citations
8.
DAINES, R. A., Pamela A. Chambers, Israil Pendrak, et al.. (1993). (E)-3-[[[[6-(2-Carboxyethenyl)-5-[[8-(4-methoxyphenyl)octyl]oxy]-2-pyridinyl]methyl]thio]methyl]benzoic acid: a novel high-affinity leukotriene B4 receptor antagonist. Journal of Medicinal Chemistry. 36(18). 2703–2705. 7 indexed citations
9.
DAINES, R. A., Pamela A. Chambers, Israil Pendrak, et al.. (1993). Additions and Corrections - (E)-3-[[[[[6-(2-Carboxyethenyl)-5-[[8-(4-methoxyphenyl)octy-1]oxy]-2-pyridinyl]methyl]thio]methyl]benzoic Acid: A Novel High-Affinity Leukotriene B4 Receptor Antagonist.. Journal of Medicinal Chemistry. 36(25). 4130–4130. 1 indexed citations
10.
Brooks, David P., Matthew J. Cyronak, M. Ann Bryant, et al.. (1990). Identification of fenoldopam prodrugs with prolonged renal vasodilator activity.. Journal of Pharmacology and Experimental Therapeutics. 254(3). 1084–1089. 6 indexed citations
11.
DeWolf, Walter E., Pamela A. Chambers, Christopher Southan, David Saunders, & Lawrence I. Kruse. (1989). Inactivation of dopamine .beta.-hydroxylase by .beta.-ethynyltyramine: kinetic characterization and covalent modification of an active site peptide. Biochemistry. 28(9). 3833–3842. 20 indexed citations
12.
Kruse, Lawrence I., Carl Kaiser, Walter E. DeWolf, et al.. (1988). .beta.-Substituted phenethylamines as high-affinity mechanism-based inhibitors of dopamine .beta.-hydroxylase. Journal of Medicinal Chemistry. 31(4). 704–706. 28 indexed citations
13.
Kruse, Lawrence I., Walter E. DeWolf, Pamela A. Chambers, & Paula J. Goodhart. (1986). Design and kinetic characterization of multisubstrate inhibitors of dopamine .beta.-hydroxylase. Biochemistry. 25(23). 7271–7278. 29 indexed citations
14.
Pfeiffer, Francis R., et al.. (1984). ChemInform Abstract: TRI‐ AND TETRAPEPTIDE ANALOGS OF KININS AS POTENTIAL RENAL VASODILATORS. Chemischer Informationsdienst. 15(32). 4 indexed citations
15.
Pfeiffer, Francis R., et al.. (1984). Tri- and tetrapeptide analogs of kinins as potential renal vasodilators. Journal of Medicinal Chemistry. 27(3). 325–341. 9 indexed citations
16.
Pfeiffer, Francis R., James W. Wilson, Joseph Weinstock, et al.. (1982). Dopaminergic activity of substituted 6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines. Journal of Medicinal Chemistry. 25(4). 352–358. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lain‐Yen Hu Breakdown of academic impact, for papers by John M. Wetzel Breakdown of academic impact, for papers by Michael Arnold Breakdown of academic impact, for papers by Hiroshi Ohtaka Breakdown of academic impact, for papers by Vittorio Vecchietti Breakdown of academic impact, for papers by R. Gnana Ravi Breakdown of academic impact, for papers by Jayana P. Lineswala Breakdown of academic impact, for papers by Kethireddy V.V. Ananthalakshmi Breakdown of academic impact, for papers by Pascal Rigollier Breakdown of academic impact, for papers by Meena Patel
Rankless by CCL
2026